Mitsubishi UFJ Asset Management Co. Ltd. Purchases 55,129 Shares of Danaher Corporation $DHR

Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 4.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,340,152 shares of the conglomerate’s stock after acquiring an additional 55,129 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.19% of Danaher worth $308,771,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $26,000. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners bought a new stake in Danaher in the third quarter valued at approximately $32,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 10.80% of the stock is currently owned by company insiders.

Danaher Stock Performance

NYSE:DHR opened at $174.69 on Wednesday. The company has a market cap of $123.64 billion, a price-to-earnings ratio of 33.79, a PEG ratio of 2.33 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $172.34 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a fifty day moving average price of $192.65 and a 200-day moving average price of $213.03.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm earned $1.88 earnings per share. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, equities analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on DHR shares. Guggenheim reduced their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Wolfe Research cut their price objective on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Barclays decreased their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Finally, Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Eighteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $240.70.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.